[Clinical significance of T lymphocyte subset changes after first line chemotherapy in peripheral blood from patients with advanced stage adenocarcinoma cell lung cancer].

about

[Clinical significance of T lymphocyte subset changes after first line chemotherapy in peripheral blood from patients with advanced stage adenocarcinoma cell lung cancer].

Item

http://www.wikidata.org/entity/Q55431535

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

[Clinical significance of T ly ...... nocarcinoma cell lung cancer].

@en

[Clinical significance of T ly ...... nocarcinoma cell lung cancer].

@nl

type

Item

label

[Clinical significance of T ly ...... nocarcinoma cell lung cancer].

@en

[Clinical significance of T ly ...... nocarcinoma cell lung cancer].

@nl

prefLabel

[Clinical significance of T ly ...... nocarcinoma cell lung cancer].

@en

[Clinical significance of T ly ...... nocarcinoma cell lung cancer].

@nl

P1476

[Clinical significance of T ly ...... nocarcinoma cell lung cancer].

@en

P2093

Liangliang Wu

http://www.w3.org/2001/XMLSchema#string

Shengjie Sun

http://www.w3.org/2001/XMLSchema#string

Shunchang Jiao

http://www.w3.org/2001/XMLSchema#string

Xiang Yan

http://www.w3.org/2001/XMLSchema#string

Xiao Zhao

http://www.w3.org/2001/XMLSchema#string

Zhiyong Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia.

Regulatory T cells in cancer.

CD25+ regulatory T cells and tumor immunity.

Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.

Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis.

Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells.

Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma.

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma.

A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patients.

P304

164-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2012.03.06

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22429580

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

lymphocyte

P932

5999878

http://www.w3.org/2001/XMLSchema#string